Editorial
doi: 10.1056/NEJMe1716802.
Epub 2018 Apr 18.
Making Sense of Triple Inhaled Therapy for COPD
Affiliations
- PMID: 29669218
- DOI: 10.1056/NEJMe1716802
Item in Clipboard
Editorial
Making Sense of Triple Inhaled Therapy for COPD
N Engl J Med.
.
No abstract available
Comment in
-
Inhaled triple therapy in chronic obstructive pulmonary disease - Authors' reply.Lancet. 2018 Sep 29;392(10153):1113-1114. doi: 10.1016/S0140-6736(18)31778-1. Lancet. 2018. PMID: 30303077 No abstract available.
Comment on
-
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.N Engl J Med. 2018 May 3;378(18):1671-1680. doi: 10.1056/NEJMoa1713901. Epub 2018 Apr 18. N Engl J Med. 2018. PMID: 29668352 Clinical Trial.
Similar articles
-
Triple inhaled therapy versus dual inhaled therapy for COPD.Drug Ther Bull. 2019 Jan;57(1):3. doi: 10.1136/dtb.2018.000048. Drug Ther Bull. 2019. PMID: 30567846 No abstract available.
-
Triple Inhaled Therapy in COPD. Reply.N Engl J Med. 2020 Oct 1;383(14):1394-1395. doi: 10.1056/NEJMc2026881. N Engl J Med. 2020. PMID: 32997922 No abstract available.
-
The efficacy and safety of triple inhaled treatment in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis using Bayesian methods.Int J Chron Obstruct Pulmon Dis. 2015 Nov 3;10:2365-76. doi: 10.2147/COPD.S93191. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26604734 Free PMC article. Review.
-
Triple combinations in chronic obstructive pulmonary disease - is three better than two?Expert Opin Pharmacother. 2014 Dec;15(17):2475-8. doi: 10.1517/14656566.2014.972367. Epub 2014 Oct 18. Expert Opin Pharmacother. 2014. PMID: 25327264
-
Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?Expert Opin Pharmacother. 2011 Aug;12(12):1913-32. doi: 10.1517/14656566.2011.589837. Epub 2011 Jun 30. Expert Opin Pharmacother. 2011. PMID: 21714776 Review.
Cited by
-
Mortality prevention as the centre of COPD management.ERJ Open Res. 2024 Jun 17;10(3):00850-2023. doi: 10.1183/23120541.00850-2023. eCollection 2024 May. ERJ Open Res. 2024. PMID: 38887682 Free PMC article. Review.
-
Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework.Respir Res. 2023 Sep 29;24(1):239. doi: 10.1186/s12931-023-02545-9. Respir Res. 2023. PMID: 37775734 Free PMC article.
-
Rational use of inhaled corticosteroids for the treatment of COPD.NPJ Prim Care Respir Med. 2023 Jul 24;33(1):27. doi: 10.1038/s41533-023-00347-6. NPJ Prim Care Respir Med. 2023. PMID: 37488104 Free PMC article. Review.
-
Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2023 Jun 5;6(6):CD012066. doi: 10.1002/14651858.CD012066.pub3. Cochrane Database Syst Rev. 2023. PMID: 37276335 Free PMC article. Review.
-
Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials.JAMA. 2023 Apr 25;329(16):1376-1385. doi: 10.1001/jama.2023.4221. JAMA. 2023. PMID: 37097356 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
